Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 15.02
(-0.86%)
CNY 15.02
(-0.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 894.38 Million CNY | 30.48% |
| 2022 | 690.63 Million CNY | 40.13% |
| 2021 | 492.86 Million CNY | 14.64% |
| 2020 | 429.9 Million CNY | -2.39% |
| 2019 | 440.42 Million CNY | 39.14% |
| 2018 | 316.53 Million CNY | 36.47% |
| 2017 | 231.93 Million CNY | 29.48% |
| 2016 | 179.13 Million CNY | 45.73% |
| 2015 | 122.92 Million CNY | 59.98% |
| 2014 | 76.83 Million CNY | 33.54% |
| 2013 | 57.53 Million CNY | 22.37% |
| 2012 | 47.01 Million CNY | -6.7% |
| 2011 | 50.39 Million CNY | -0.19% |
| 2010 | 50.49 Million CNY | 29.81% |
| 2009 | 38.89 Million CNY | 26.78% |
| 2008 | 30.67 Million CNY | 48.78% |
| 2007 | 20.62 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 173.68 Million CNY | -10.51% |
| 2024 Q2 | 194.07 Million CNY | -8.07% |
| 2024 Q1 | 211.11 Million CNY | 18.54% |
| 2023 Q2 | 244.1 Million CNY | 15.02% |
| 2023 Q3 | 266.68 Million CNY | 9.25% |
| 2023 Q4 | 178.1 Million CNY | -33.22% |
| 2023 FY | 901.11 Million CNY | 30.48% |
| 2023 Q1 | 212.22 Million CNY | 64.34% |
| 2022 Q3 | 247.44 Million CNY | 31.64% |
| 2022 FY | 690.63 Million CNY | 40.13% |
| 2022 Q4 | 129.14 Million CNY | -47.81% |
| 2022 Q2 | 187.97 Million CNY | 49.1% |
| 2022 Q1 | 126.06 Million CNY | 29.07% |
| 2021 FY | 492.86 Million CNY | 14.64% |
| 2021 Q3 | 144.34 Million CNY | 22.57% |
| 2021 Q1 | 133.08 Million CNY | 20.56% |
| 2021 Q2 | 117.76 Million CNY | -11.51% |
| 2021 Q4 | 97.67 Million CNY | -32.33% |
| 2020 Q4 | 110.38 Million CNY | -6.94% |
| 2020 FY | 429.9 Million CNY | -2.39% |
| 2020 Q3 | 118.61 Million CNY | 18.08% |
| 2020 Q2 | 100.45 Million CNY | 0.01% |
| 2020 Q1 | 100.44 Million CNY | -22.31% |
| 2019 Q4 | 129.28 Million CNY | -3.28% |
| 2019 FY | 440.42 Million CNY | 39.14% |
| 2019 Q1 | 71.81 Million CNY | -26.12% |
| 2019 Q2 | 105.65 Million CNY | 47.13% |
| 2019 Q3 | 133.66 Million CNY | 26.51% |
| 2018 Q2 | 82.03 Million CNY | 31.87% |
| 2018 Q1 | 62.21 Million CNY | -3.33% |
| 2018 FY | 316.53 Million CNY | 36.47% |
| 2018 Q4 | 97.2 Million CNY | 29.47% |
| 2018 Q3 | 75.07 Million CNY | -8.48% |
| 2017 FY | 231.93 Million CNY | 29.48% |
| 2017 Q4 | 64.35 Million CNY | 16.28% |
| 2017 Q3 | 55.34 Million CNY | -11.06% |
| 2017 Q2 | 62.22 Million CNY | 24.43% |
| 2017 Q1 | 50.01 Million CNY | 9.75% |
| 2016 Q4 | 45.56 Million CNY | 5.18% |
| 2016 FY | 179.13 Million CNY | 45.73% |
| 2016 Q1 | 40.65 Million CNY | 0.71% |
| 2016 Q2 | 49.58 Million CNY | 21.96% |
| 2016 Q3 | 43.32 Million CNY | -12.62% |
| 2015 Q3 | 31.32 Million CNY | 21.03% |
| 2015 FY | 122.92 Million CNY | 59.98% |
| 2015 Q1 | 25.33 Million CNY | 17.65% |
| 2015 Q2 | 25.88 Million CNY | 2.16% |
| 2015 Q4 | 40.37 Million CNY | 28.86% |
| 2014 Q1 | 14.02 Million CNY | 5.68% |
| 2014 FY | 76.83 Million CNY | 33.54% |
| 2014 Q4 | 21.53 Million CNY | -2.09% |
| 2014 Q3 | 21.99 Million CNY | 14.09% |
| 2014 Q2 | 19.27 Million CNY | 37.47% |
| 2013 Q4 | 13.27 Million CNY | -13.63% |
| 2013 Q2 | 16.46 Million CNY | 32.42% |
| 2013 Q3 | 15.36 Million CNY | -6.7% |
| 2013 Q1 | 12.43 Million CNY | 6.12% |
| 2013 FY | 57.53 Million CNY | 22.37% |
| 2012 Q4 | 11.71 Million CNY | 13.74% |
| 2012 Q1 | 10.5 Million CNY | 2.16% |
| 2012 FY | 47.01 Million CNY | -6.7% |
| 2012 Q2 | 14.49 Million CNY | 37.99% |
| 2012 Q3 | 10.3 Million CNY | -28.91% |
| 2011 Q1 | 11.62 Million CNY | -10.22% |
| 2011 Q3 | 13.53 Million CNY | -8.05% |
| 2011 FY | 50.39 Million CNY | -0.19% |
| 2011 Q4 | 10.28 Million CNY | -24.04% |
| 2011 Q2 | 14.71 Million CNY | 26.6% |
| 2010 Q1 | 12.55 Million CNY | 44.65% |
| 2010 Q2 | 14.22 Million CNY | 13.3% |
| 2010 FY | 50.49 Million CNY | 29.81% |
| 2010 Q4 | 12.95 Million CNY | 20.25% |
| 2010 Q3 | 10.76 Million CNY | -24.26% |
| 2009 Q3 | 13.06 Million CNY | 0.0% |
| 2009 Q4 | 8.67 Million CNY | -33.58% |
| 2009 FY | 38.89 Million CNY | 26.78% |
| 2008 FY | 30.67 Million CNY | 48.78% |
| 2007 FY | 20.62 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | 59.16% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | -17.274% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | -94.868% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 187.93 Million CNY | -375.904% |
| Yifan Pharmaceutical Co., Ltd. | 1.83 Billion CNY | 51.15% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 347.72 Million CNY | -157.215% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 10.7 Billion CNY | 91.643% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | -44.043% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 808 Million CNY | -10.691% |